Czasopismo Clinical and Experimental Hepatology 2019

Viral hepatitis C treatment shortening – what is the limit?

Dorota Zarębska-Michaluk

DOI: https://doi.org/10.5114/ceh.2019.88085

Abstract View text

Clinical effectiveness of MARS treatment – multidirectional analysis of positive clinical response to treatment

Wojciech Mielnicki, Agnieszka Dyla, Maciej Karczewski

DOI: https://doi.org/10.5114/ceh.2019.89163

Abstract View text

Lymphovascular invasion on explant is associated with presenting tumor characteristics and not direct acting antiviral utilization in hepatitis C candidates undergoing liver transplantation

Paul Muna-Aguon, Meera Ramanathan, Myunghan Choi, Mark Pedersen, Anil Seetharam

DOI: https://doi.org/10.5114/ceh.2019.88105

Abstract View text

IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis

Fatemeh Farahmand, Mitra Ahmadi, Ahmad Khodadad, Mehri Najafi, Gholamhossein Fallahi, Farzaneh Motamed, Masoud Movahedi, Asghar Aghamohammadi, Nima Rezaei, Hazhir Javaherizadeh

DOI: https://doi.org/10.5114/ceh.2019.89119

Abstract View text

Outpatient versus inpatient follow-up for intrahepatic cholestasis of pregnancy

Ozgur Ozyuncu, Gokcen Orgul, Gonca Ozten, Murat Yurdakok, Mehmet Sinan Beksac

DOI: https://doi.org/10.5114/ceh.2019.88616

Abstract View text

Missed opportunities for diagnosing viral hepatitis C in Poland. Results from routine HCV testing at the Emergency Department in the Hospital for Infectious Diseases in Warsaw

Karolina Agnieszka Pyziak-Kowalska, Andrzej Horban, Maksymilian Bielecki, Justyna Kowalska

DOI: https://doi.org/10.5114/ceh.2019.89148

Abstract View text

Clinical audit to determine efficacy of daily infusion of low dose of 20% albumin in combination with antibiotics in patients with spontaneous bacterial peritonitis

Uday Sanglodkar, Mayank Jain, Joy Vargese, Chandankumar Kedarisetty, Jayanthi Venkataraman

DOI: https://doi.org/10.5114/ceh.2019.88774

Abstract View text

Expression of vascular endothelial growth factor A in liver tissues of infants with biliary atresia

Alif Allam, Mohammed El-Guindi, Hatem Konsowa, Dina El. Azab, Maha Allam, Tahany Salem, Haidy Mohammed Zakaria

DOI: https://doi.org/10.5114/ceh.2019.89476

Abstract View text

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma

Azhar Mohamed Nomair, Marwa Ahmed Madkour, Mohammed Mohammed Shamseya, Heba Gaber Elsheredy, Ahmed Shokr

DOI: https://doi.org/10.5114/ceh.2019.89478

Abstract View text

The usefulness of commercially available serological tests in the diagnosis and monitoring of treatment in patients with alveolar echinococcosis

Małgorzata Sulima, Beata Szostakowska, Wacław Nahorski, Katarzyna Sikorska, Wojciech Wołyniec, Piotr Wąż

DOI: https://doi.org/10.5114/ceh.2019.89480

Abstract View text

Viral hepatitis C treatment shortening – what is the limit?

Clinical effectiveness of MARS treatment – multidirectional analysis of positive clinical response to treatment

Lymphovascular invasion on explant is associated with presenting tumor characteristics and not direct acting antiviral utilization in hepatitis C candidates undergoing liver transplantation

IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis

Outpatient versus inpatient follow-up for intrahepatic cholestasis of pregnancy

Missed opportunities for diagnosing viral hepatitis C in Poland. Results from routine HCV testing at the Emergency Department in the Hospital for Infectious Diseases in Warsaw

Clinical audit to determine efficacy of daily infusion of low dose of 20% albumin in combination with antibiotics in patients with spontaneous bacterial peritonitis

Expression of vascular endothelial growth factor A in liver tissues of infants with biliary atresia

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma

The usefulness of commercially available serological tests in the diagnosis and monitoring of treatment in patients with alveolar echinococcosis

Coverage in

Integrated with

Editorial Policies